Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.

Kandala Aparna SharmaNilanchali SinghSara HillmanPurva MathurKapil YadavAnapti GargVatsla DadhwalNeerja Bhatla

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2022)

First trimester sero-molecular screening suggests a high prevalence of COVID antibodies in the study population of pregnant women in the first trimester, without the patients being symptomatic.

Keyphrases

sars cov
pregnant women
coronavirus disease
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
pregnancy outcomes
patient reported outcomes